Citation :

Amruta Sonawane, Atharva Hastekar, Amit Kakad, M.R.N Shaikh, Roma Sharma, "Herbal Bio-Actives: A Key for Bioavailability Enhancement of Drugs," International Journal of Computer Trends and Technology (IJCTT), vol. 13, no. 2, pp. 8-19, 2023. Crossref, https://doi.org/10.14445/22490183/ IJBTT-V13I2P602

Abstract

Background: In recent years, there has been a major interest and medical need for the enhancement of the bioavailability of several drugs which are poorly bioavailable. Poorly bioavailable drugs remain sub-therapeutic because a considerable portion of a dose never enters the plasma or exerts its pharmacological action unless and until very large doses are delivered. bioenhancers play a key role in raising the bioavailability and efficacy of a variety of pharmacological drugs at minimal doses. Main Body: The present work’s main goal is to review bioenhancers, their modes of action, characteristics, classification, overview, and formulation in the market of bioenhancers. Importance of Fulvic Acid, Gelucire, Naringin, Esters of gallic acid, Cumin, Ginger, Caraway, Piperine, Sinomenine, Genistein, Lysergol, Cow urine distillate, Nitrile glycoside, Glycyrrhizin, Capmul, Gokhru and, Aloe vera gel as bioenhancers. Conclusion: The various bioenhancers, emphasizing their distinct modes of actions, applications, and their safe dose and drugs bio-enhanced by them. It also focuses on the most recent breakthrough notion of using bio-enhancers to improve the bioavailability/bio-efficacy of low-bioavailability medications, metals, nutraceuticals, and vitamins through various techniques. Therefore, Extensive research on these bio-enhancers should be carried out so that they can be utilized in drug formulations.

Keywords

Bioenhancer, Bioavailability, Bio-efficacy, Herbal, Bio-actives.

References

[1] Rajendra Prasa et al., “Role of Bioenhancers in Tuberculosis,” International Journal of Health Sciences, vol. 6, no. 6, pp. 307-313, 2016.
[Google Scholar] [Publisher Link]

[2] Ashoka Shenoy M, and Nitin Mahurkar, “The Mechanism of Actions for Herbal Bioenhancers,” RGUHS Journal of Pharmaceutical Sciences, vol. 11, no. 2, pp. 1-4, 2021.
[CrossRef] [Google Scholar] [Publisher Link]

[3] Kumar Sandeep et al., “Novel Approaches for Enhancement of Drug Bioavailability,” Reviews in Advanced Sciences and Engineering, vol. 2, no. 2, pp. 133-154, 2013.
[CrossRef] [Google Scholar] [Publisher Link]

[4] A.V.Kadam et al., "Use of Herbal Drugs and Its Effect on CD4 Count in HIV Infected Individuals Taking Antiretroviral Therapy in Pune," SSRG International Journal of Medical Science, vol. 5, no. 8, pp. 4-8, 2018.
[CrossRef] [Google Scholar] [Publisher Link]

[5] Dhanlaxmi Pinisetti, Jagdish Kakadiya, and G. S. Chakroborthy, “Recent Trends on Natural Bioenhancers: An Overview,” Asian Journal of Research in Chemistry and Pharmaceutical Sciences, vol. 7, no. 2, pp. 708–725, 2019.
[Google Scholar] [Publisher Link]

[6] Suraj Prakash Agarwal, Mohammad Khalid Anwer, and Mohammad Aqil, “Complexation of Furosemide with Fulvic Acid Extracted From Shilajit: A Novel Approach,” Drug Development and Industrial Pharmacy, vol. 34, no. 5, pp. 506-511, 2008.
[CrossRef] [Google Scholar] [Publisher Link]

[7]  Bianca Peterson et al., “Drug Bioavailability Enhancing Agents of Natural Origin (Bioenhancers) That Modulate Drug Membrane Permeation and Pre-Systemic Metabolism,” Pharmaceutics, vol. 11, no. 1, pp. 30-33, 2019.
[CrossRef] [Google Scholar] [Publisher Link]

[8] Kahnu Charan Panigrahi et al., “Gelucire: A Versatile Polymer for Modified Release Drug Delivery System,” Future Journal of Pharmaceutical Sciences, vol. 4, no. 1, pp. 102-108, 2018.
[CrossRef] [Google Scholar] [Publisher Link]

[9] Chavhan SA., Shinde SA., and Gupta IN., “Current Trends on Natural Bio Enhancers: A Review,” International Journal of Pharmacognosy and Chinese Medicine, vol. 2, no. 1, pp. 2576-4772, 2018.
[Google Scholar] [Publisher Link]

[10] Francis A. Oladimeji, Adebanjo J. Adegbola, and Cyprian O. Onyeji, “Appraisal of Bioenhancers in Improving Oral Bioavailability: Applications to Herbal Medicinal Products,” Journal of Pharmaceutical Research International, vol. 24, no. 4, pp. 1-23, 2018.
[CrossRef] [Google Scholar] [Publisher Link]

[11] Venkatesh Sama et al., “Bioenhancing Effects of Naringin on Atorvastatin,” ADMET and DMPK, vol. 7, no. 3, pp. 174-182, 2019.
[CrossRef] [Google Scholar] [Publisher Link]

[12] Dhanish Joseph, and Suseem Sundaram Renjitham, “The Development and Process Optimization of Atorvastatin Calcium and Naringin Bilayer Tablet to Improve the Bioavailability of Atorvastatin Calcium by Two-Level Factorial Design Using Design-Expert®,” Journal of Applied Pharmaceutical Science, vol. 11, no. 6, pp. 70-77, 2021.
[CrossRef] [Google Scholar] [Publisher Link]

[13] Bhargavi Latha Athukuri, and Prasad Neerati, “Enhanced Oral Bioavailability of Diltiazem by the Influence of Gallic Acid and Ellagic Acid in Male Wistar Rats: Involvement of CYP3A and P‐Gp Inhibition,” Phytotherapy Research, vol. 31, no. 9, pp. 1441-8, 2017.
[CrossRef] [Google Scholar] [Publisher Link]

[14] Bhargavi Latha Athukuri, and Prasad Neerati, “Enhanced Oral Bioavailability of Diltiazem by the Influence of Gallic Acid and Ellagic Acid in Male Wistar Rats: Involvement of CYP3A Inhibition,” Drug Metabolism and Personalized Therapy, vol. 31, no. 4, pp. 229–234, 2016.  
[CrossRef] [Publisher Link] 

[15] Kritika Kesarwani, and Rajiv Gupta, “Bioavailability Enhancers of Herbal Origin: An Overview,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 4, pp. 253-66, 2013.  
[CrossRef] [Google Scholar] [Publisher Link]

[16] Deepthi V. Tatiraju et al., “Natural Bioenhancers: An Overview,” Journal of Pharmacognosy and Phytochemistry, vol. 2, no. 3, pp. 55-60, 2013.
[Google Scholar] [Publisher Link]

[17] Mohammad Rashid et al., “Cumin and Residronate Loaded Chitosan Microparticles for Treatment of Osteoporosis,” International Journal of Pharma Sciences and Research, vol.  9, no. 7, pp. 83-98, 2017.
[Google Scholar] [Publisher Link]

[18] Vinod S Ipar, Anisha Dsouza, and Padma V Devarajan, “Enhancing Curcumin Oral Bioavailability Through Nanoformulations,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 44, no. 4, pp. 459-480, 2019.
[CrossRef] [Google Scholar] [Publisher Link]

[19] Ghanshyam B Dudhatra et al., “A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers,” The Scientific World Journal, vol. 2012, pp. 1-33, 2012.
[CrossRef] [Google Scholar] [Publisher Link]

[20] Ghulam Nabi Qazi et al., “Bioavailability Enchancing Activity of Zingiber Officinale Linn and Its Extracts/Fractions Thereof,” United States Patent Application US 10/318,314, 2003.
[Google Scholar] [Publisher Link]

[21] Mohaddese Mahboubi, “Caraway as Important Medicinal Plants in Management of Diseases,” Natural Products and Bioprospecting, vol. 9, no. 1, pp. 1-11, 2019. 
[CrossRef] [Google Scholar] [Publisher Link]

[22] Ajazuddin et al., “Role of Herbal Bioactives as a Potential Bioavailability Enhancer for Active Pharmaceutical Ingredients,” Fitoterapia, vol. 97, pp. 1-4, 2014.
[CrossRef] [Google Scholar] [Publisher Link]

[23] C K Atal, U Zutshi, and P G Rao, “Scientific Evidence on the Role of Ayurvedic Herbals on Bioavailability of Drugs," Journal of Ethnopharmacology, vol. 4, no. 2, pp. 229-232, 1981.
[CrossRef] [Google Scholar] [Publisher Link]

[24] Amar Singh, and Amar Deep, “Piperine: A Bioenhancer,” International Journal of Pharmacy Research and Technology, vol. 1, no. 1, pp. 01-05, 2011.
[Google Scholar] [Publisher Link]

[25] R K Reen, and J Singh, “In Vitro and in Vivo Inhibition of Pulmonary Cytochrome P450 Activities by Piperine, A Major Ingredient of Piper Species” Indian Journal of Experimental Biology, vol. 29, no. 6, pp. 568-573, 1991.
[Google Scholar] [Publisher Link]

[26] Bhise S., and Pore V., “Influence of Co-Administration of Piperine on Pharmacokinetic Profile of Ciprofloxacin,” Indian Drugs, vol. 39, pp. 166–168, 2002.
[Google Scholar]

[27] Duong Thi Thuy Linh, "Factors Influencing Synthetic Drug Use in Youth – An Experimental Case Study in Thainguyen City," SSRG International Journal of Economics and Management Studies, vol. 9,  no. 3, pp. 17-23, 2022.
[CrossRef] [Publisher Link]

[28] Kelvin Chan et al., “The Effects of Sinomenine on Intestinal Absorption of Paeoniflorin by the Everted Rat Gut Sac Model,” Journal of Ethnopharmacology, vol. 103, no. 3, pp. 425-432, 2006.
[CrossRef] [Google Scholar] [Publisher Link]

[29] M S Kurzer, and X Xu, “Dietary Phytoestrogens,” Annual Review of Nutrition, vol. 17, no. 1, pp. 353-381, 1997.
[CrossRef] [Google Scholar] [Publisher Link]

[30] Khanuja et al., “Antibiotic Pharmaceutical Compositionwith Lysergol as Bioenhancer and Method of Treatment,” United States Patent Number, 20070060604A1, 2007.
[Google Scholar] [Publisher Link]

[31] Shrikant Patil et al., “Simultaneous Quantification of Berberine and Lysergol by HPLC‐UV: Evidence That Lysergol Enhances the Oral Bioavailability of Berberine in Rats,” Biomedical Chromatography, vol. 26, no. 10, pp. 1170-11705, 2012.
[CrossRef] [Google Scholar] [Publisher Link]

[32] Prashith Kekuda T. R et al., “Cow Urine Concentrate: A Potent Agent with Antimicrobial and Anthelmintic Activity,” Journal of Pharmacy Research, vol. 3, no. 5, pp. 1025-1027, 2010.
[Google Scholar] [Publisher Link]

[33] Khan Asma, and  Srivastava Vinoy K., “Antitoxic and Bioenhancing Role of Kamdhenu Ark (Cow Urine Distillate) on Fertilitty Rate of Male Mice (Mus Musculus) Affected by Cadmium Chloride Toxicity,” International Journal of Cow Science, vol. 1, no. 2, pp. 43-46, 2005.
[Google Scholar] [Publisher Link]

[34] Chawla PC., Resorine A Novel CSIR Drug Curtails TB Treatment, CSIR News, vol. 60, pp. 52-54, 2010.
[Google Scholar]

[35] Gurpreet Kaur Randhawa, Jagdev Singh Kullar, and Rajkumar, “Bioenhancers from Mother Nature and Their Applicability in Modern Medicine,” International Journal of Applied and Basic Medical Research, vol. 1, no. 1, pp. 5-10, 2011.
[CrossRef] [Google Scholar] [Publisher Link]

[36] Reddy, SA et al., “Effect of Gokhru Plant Extract on Intestinal Absorption of Aspirin Using Everted Sac Technique,” International Journal of Pharmaceutical and Biological Archives, vol. 2, no. 1, pp. 549-553, 2011.
[Google Scholar] [Publisher Link]

[37] Ashwini Kumar, and Mayank Bansal, “Formulation and Evaluation of Antidiabetic Tablets: Effect of Absorption Enhancer,” World Journal of Pharmaceutical Research, vol. 3, pp. 1426-1445, 2014.
[Google Scholar] [Publisher Link]

[38] Elizabeth Ojewole et al., “Investigating the Effect of Aloe Vera Gel on the Buccal Permeability of Didanosine,” Planta Medica, vol. 78, no. 4, pp. 354-361, 2012.
[CrossRef] [Google Scholar] [Publisher Link]

[39] Shamama Javed, Waquar Ahsan, and Kanchan Kohli “The Concept of Bioenhancers in Bioavailability Enhancement of Drugs–A Patent Review,” Journal of Scientific Letters, vol. 1, pp. 143-65, 2016. 
[Google Scholar] [Publisher Link]

[40] Zhong Qiu Liu et al., “Influence of Co-Administrated Sinomenine on Pharmacokinetic Fate of Paeoniflorin in Unrestrained Conscious Rats,” Journal of Ethnopharmacology, vol. 99, no. 1, pp. 61-67, 2005.
[CrossRef] [Google Scholar] [Publisher Link]